Every milestone at Strides has left behind a footprint of achievement and success. And a story of the commitment, dedication and trust of our employees, customers and partners.
Entered into collaboration with Pfizer to license and supply 40 off-patent products, largely oncology products, for the USA market; bought Campos facility in Brazil from Aspen
Extended Pfizer transaction to cover Canada, Australia, European Union, Japan, New Zealand and Korea; rebranded Specialty division as Agila Specialties Private Limited; acquired controlling stake in Inbiopro Solutions to enter biopharmaceuticals segment
Rebranded Specialty Division as Agila Specialties Private Limited
Acquired biotechnology company Inbiopro Solutions to enter the biologics space
Formed a joint venture with Sagent Pharmaceuticals for specialty products in USA
Acquired Grandix, a leading brand marketing company, to enter the Indian domestic market;
bought out stake and acquired 100% ownership of Farma Plus AS in Norway
Ceded 50% ownership in LATAM operations to Aspen Group
Formed a joint venture with Aspen Group to set up an Oncology facility in India
Entered into an alliance with the Clinton Foundation for supplying AIDS drugs; acquired ICN Valeant Sterile's manufacturing unit in Poland; acquired a controlling stake in Beltapharm SpA in Italy; acquired Drug Houses of Australia (Asia) Pte Limited, Singapore; entered into a joint venture with Invent Farma in Spain to market products in the Spanish and Portuguese markets
